IL6 and coronary artery disorder: NFKBIA polymorphisms modulated the risk of coronary artery disease in the Chinese Uygur population by regulating various cytokines including interleukin-6, which is a key mediator of the inflammatory process and atherosclerotic plaque formation (48).